Digital healthcare startup ODIEN (CEO Sang-yeol Lee) has been selected for the '2025 First Bio-Health Research and Development Project' hosted by the Ministry of Trade, Industry and Energy. This project is worth a total of 4.95 billion won and will be carried out for approximately 4 years and 9 months from the second half of 2025 to 2029.
ODIEN will participate in a research led by the medtech company Answer, along with Kyung Hee Medical Center and Korea University Guro Hospital, to jointly develop an 'AI-based critical trauma patient bio-signal monitoring and real-time early warning system (BiCON)'. BiCON is a smart medical solution that analyzes a patient's bio-data in real time using artificial intelligence to detect rapid changes in the body and abnormal signs early and quickly notify medical staff.
ODIEN will work with the Kyung Hee Medical Center research team to conduct a linkage test between the hospital’s electronic medical record (EMR) system and the AI early warning system. Located in the Seoul Bio Hub Industry-Academic Cooperation Building, ODIEN plans to utilize the research infrastructure of Kyung Hee Medical Center and Seoul Bio Hub to optimize real-time data flow and improve the user interface.
ODIEN CEO Lee Sang-yeol said, “Urgency and expertise are essential for treating severely injured patients, and skilled personnel and precise surveillance systems are important for this,” adding, “Through this project, we will implement a smart solution that enhances the speed and accuracy of treatment, and do our best to enhance the competitiveness of domestic digital healthcare technology.”
- See more related articles
You must be logged in to post a comment.